After a Successful TAVI

Slides:



Advertisements
Similar presentations
The management of empyema the practical vs. ideal approach R. Masekela University of Pretoria.
Advertisements

STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.
Case #1 Bicuspid Valve Dilated Aortic Root Mod AI/Mild AS - RW
Alsharqia.riyadh Echo meeting Dammam KSA SAYED ABOU EL SOUD MD SBCC.
Common Clinical Scenarios *Younger people *Younger people _Functional murmur vs _Functional murmur vs _ MVP vs _ MVP vs _ AS _ AS *Older people _Aortic.
RJS Valvular heart disease Richard Schilling St Mary’s Hospital London.
Two Cardiac Centres Are Better Than One Early Outcomes of the First 75 Open Heart Surgeries At Port of Spain General Hospital Randolph Rawlins M.B.B.S.,
Mitral Valve Disease Prof JD Marx UFS January 2006.
Pacemaker and Lead Infections Alpay Celiker MD. Hacettepe University Ankara, Turkey Case Based Tutorial Heart Rhythm May Boston, USA.
Causes of valve disease Valve regurgitation * Congenital *Acute rheumatic carditis *Chronic rhe. Carditis * I E *Syphlitic aortitis *Dilated Valve.
A shifting paradigm of care: Advances in transcatheter heart valve procedures Sandra Lauck MSN, RN, CCN(C) Clinical Nurse Specialist, Arrhythmia Management.
Aortic Valve Peravalvular Leak. Risk factors for Aortic Valve Peravalvular Leak u Endocarditis u calcified annulus u bicuspid aortic valve –Note many.
Department of CTVS.  56 years old male from Cuttack  Date of admission  Date of surgery  Date of death  Diagnosis:
Valvular Hemodynamics Morton J. Kern, MD Professor of Medicine Chief of Cardiology Associate Chief Cardiology University California Irvine Orange, California.
Surgical outcome of native valve infective endocarditis in srinagarind hospital
Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor of Medicine Chief of Cardiology Associate Chief Cardiology.
By Tyra Whye, Graham Rubin, and Noah Kaplan DOCTOR!
Prosthetic heart valves: management of usual and unusual complications January 14 th, h-15h30.
EXPANDING INDICATIONS OF TRANSCATHETER HEART VALVE INTERVENTIONS. JACC CARDIOVASCULAR INTERVENTION. DR.RAJAT GANDHI.
Primary Mitral Regurgitation Degenerative Mitral Valve Disease
1 Jeffrey J. Popma, MD Professor of Medicine Harvard Medical School Director, Interventional Cardiology Beth Israel Deaconess Medical Center Boston, MA.
TAVR in Patients With Chronic Kidney Disease
VSD post TAVR: Mechanisms, Presentation and Management
Endocarditis Tutoring
August 9th 2016 Structural Heart Live: ND, 89 yr.F
Extending the Boundaries of TAVR: Future Directions
Trans- catheter aortic valve replacement vs
Late breaking news in heart valve disease
MY WORST CASE OF THE YEAR
Aortic Valve Peravalvular Leak
Raj R. Makkar, MD On behalf of The PARTNER Trial Investigators
Direct Flow Medical Experience with a Conformable, Repositionable, Retrievable, Percutaneous Aortic Valve Reginald Low MD University of California,Davis.
TAVR-Endocarditis Tarek Chami, MD
University of Cincinnati Medical Center
TAVR in Patients with Chronic Lung Disease
Infective endocarditis
30 Day Outcomes from the SOURCE XT TAVI Post Approval Study
Is There a Need to Address AF in patients Undergoing Valve Surgery?
PRE AND POST SURGERY IMAGES
First Report of Three-Year Outcomes With the Repositionable and Fully Retrievable Lotus™ Aortic Valve Replacement System: Results From the REPRISE I.
TAVI Passed the Exam and is Ready for Clinical Use in Inoperable Patients Disclosures Research Funding and Speaking Honoraria: Edwards Lifesciences.
5th Meeting on Acute Cardiac Care and Emergency Medicine, 2016 Vilnius
Direct Flow Medical Experience with a Conformable, Repositionable Retrievable Percutaneous Aortic Valve Reginald Low MD University of California, Davis.
TAVI „Catch me if you can!“
Brucella endocarditis fatal but underdiagnosed
Paravalvular Leak Closure Case Presentation
Longevity of transcatheter and surgical bioprosthetic aortic valves in patients with severe aortic stenosis and lower surgical risk Lars Sondergaard,
Choosing the valve type for AVR in old patients.
Progress with the Sadra Medical Lotus™ Valve System
Instituto de Ciencias del Corazón
Complex PCI to CTO lesion in RCA with nightmares complications
Structural Heart Live Cases
pregnancy in Heart disease
Managing and Correcting a "Frozen" Leaflet after TAVR
SEVERE BACK PAIN AFTER BELOW KNEE AMPUTATION- NOT ALWAYS MECHANICAL!
Dynamic Mitral Valve Ring Annuloplasty: Micardia Concept
ADULT ECHOCARDIOGRAPHY Lesson Seven The Mitral Valve
University Heart Center Hamburg
Progress Toward a Percutaneously Adjustable Mitral Ring: Micardia
Balloon-Expandable Transcatheter Valve System : OUS Data
Kyle D Buchanan, MD MedStar Washington Hospital Center
Jay Giri, MD, MPH Massachusetts General Hospital Boston, MA
Samir R. Kapadia, MD On behalf of The PARTNER Trial Investigators
ADULT ECHOCARDIOGRAPHY Lesson Seven The Mitral Valve
Zoll Firm Lecture Series
CLINICAL PROBLEM SOLVING
CLINICAL PROBLEM SOLVING
Deterministic univariate sensitivity analyses (BAV, balloon aortic valvuloplasty; ICU, intensive care unit; MM, medical management; QALY, quality-adjusted.
T Salah, MD., M Saber, MBBCh., T ElTaweil, MD. and N Rasmy,MD.
Case 5 Revision surgery after pertrochanteric fracture
Presentation transcript:

After a Successful TAVI A Nasty Surprise After a Successful TAVI 20 Andrew Cassar, Mark Abela, Albert Fenech Mater Dei Hospital, MALTA

Speaker’s name: Andrew Cassar ❒ I have the following potential conflicts of interest to report: ❒ Consulting ❒ Employment in industry ❒ Stockholder of a healthcare company ❒ Owner of a healthcare company ❒ Other(s)  I do not have any potential conflict of interest

Presentation 85 year old gentleman PVD (toe amputation), AF, CHF Several hospital admissions since Jan 09 with chest pain, pulm oedema, and recurrent pleural effusion Dec 09 found to have severe AS on TTE: Max Vel 5.8m/s, Max Grad 133mmHg, Mean 90mmHg, AVA 0.7 cm2 Logistic Euroscore 11% STS 6.5% Turned down for SAVR by cardiac surgeons due to high risk

Balloon Aortic Valvuloplasties February 2011 during readmission for pulm oedema pt underwent successful BAV (gradient down to 40 mmHg) Cor angio showed significant disease in small RCA Patient was well for a few months and was scheduled for a TF TAVI in July 2011 In the end of June 2011 admitted with pulm oedema and deterioration in general condition, hypotension, anorexia Repeat BAV was done with minimal improvement Scheduled for trans-aortic TAVI 4 days later

l TAVI procedure Edwards Sapien valve successfully deployed via ascending aorta route Under General anaesthesia, CV line, TOE Pigtail and temporary pacemaker via Right groin 1g of i.v. Vancomycin prophylaxis given at induction

Post-TAVI 3 days in ICU Intensive physiotherapy during admission Discharged after 22 days Improved NYHA & Pressure Gradient

Patient Presentation Post-TAVI Patient re-admitted 2 days post-discharge with deterioration in general condition, unable to swallow, anorexic, On examination, patient was noted to be dehydrated, afebrile, few basal crepitations R>L – Impression: Chest infection and Dehydration Patient was started on IV fluids, Naso-Gastric Tube inserted and co-amoxiclav 1.2g tds in view of a possible pneumonia – patient steadily improved ESR 44 and CRP 73, normal WCC

An ECHO showed a large (25 x 5 mm) vegetation at the base of the posterior leaflet of the mitral valve that was prolapsing in the LA with minimal MR. Prosthetic Aortic Valve was intact with mild paravalvular leakage.

Management of IE Two sets of blood cultures were taken. Patient was started empirically with Gentamicin and Vancomycin. Enterococcus faecalis was cultured, Pathogen sensitive to amoxicillin and antibiotic changed accordingly. Patient general condition improved, ESR and CRP came down

Why did the IE happen? IE is a known complication of BAV (3 case reports all aortic IE) IE is a known complication of TAVI (1% of SOURCE registry patients in 1 yr) Incidental? Recurrent interventions (2 BAV + 1 TAVI) may have put patient at a higher risk of endocarditis Why mitral IE not aortic? Circulation. 2011 Jul 26;124(4):425-33 Ann Thorac Surg. 1993 Nov;56(5):1161-2 Am Heart J. 1988 Jan;115(1 Pt 1):178-9 Am Heart J. 1992 Jul;124(1):223-5.

Learning experience IE tends to have atypical and insidious presentations in the elderly Don’t rush off to intervention if patients waiting for a TAVI deteriorate suddenly Should we give antibiotic prophylaxis before BAV? Does delaying TAVI increase risk? Should Vancomycin have been given earlier?

Thank You!